Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964–2003 followed up to the end of 2006

Figures & data

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of cervix uteri by country. Nordic cancer survival study 1964–2003.

Table I. Trends in survival for cancer of cervix uteri by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Women
1964–1968	4 489	59 (57–61)	2 084	59 (56–62)	125	39 (31—49)	1 883	60 (57–63)	4 608	59 (57–61)
1969–1973	3 947	60 (58–61)	1 593	62 (59–65)	90	65 (54–78)	2 081	63 (61–66)	3 823	60 (58–62)
1974–1978	3 492	58 (56–60)	1 185	62 (59–65)	53	62 (53–74)	2 203	66 (64–68)	3 076	62 (60–64)
1979–1983	3 002	59 (57–61)	972	61 (57–64)	76	62 (53–74)	1 891	65 (62–67)	2 791	62 (60–64)
1984–1988	2 740	61 (59–63)	783	59 (55–62)	74	74 (61–90)	1 645	63 (60–65)	2 552	63 (61–65)
1989–1993	2 629	62 (60–64)	715	61 (58–65)	66	71 (59–84)	1 798	64 (62–67)	2 446	65 (63–67)
1994–1998	2 296	65 (62–67)	814	65 (62–69)	75	60 (48–75)	1 664	67 (65–70)	2 325	65 (63–67)
1999–2003	1 991	64 (62–66)	787	67 (65–70)	76	64 (54–76)	1 475	68 (66–70)	2 251	65 (64–67)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Table II. Trends in 5-year age-specific relative survival in percent after cancer of cervix uteri by country. Nordic cancer survival study 1964–2003.

	Women
Age	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	70	60	60	46	23	0
1969–1973	74	63	56	43	24	0
1974–1978	72	61	57	40	26	0
1979–1983	78	57	52	44	22	0
1984–1988	81	57	54	43	27	28
1989–1993	81	65	57	40	28	0
1994–1998	82	65	61	47	26	16
1999–2003	83	68	54	44	26	9
Finland
1964–1968	71	60	52	48	43	*
1969–1973	80	64	55	42	36	*
1974–1978	74	68	59	43	35	*
1979–1983	76	60	56	49	30	0
1984–1988	73	64	50	48	22	*
1989–1993	80	66	54	41	20	0
1994–1998	82	62	61	50	34	0
1999–2003	85	63	63	50	43	74
iceland
1964–1968	61	60	11	14	14	*
1969–1973	82	71	69	28	28	*
1974–1978	79	60	66	35	35	*
1979–1983	79	60	66	35	35	*
1984–1988	83	103	43	67	67	*
1989–1993	84	77	77	37	37	*
1994–1998	84	64	48	31	31	*
1999–2003	92	77	34	40	40	*
Norway
1964–1968	75	64	60	40	15	*
1969–1973	78	67	59	47	25	*
1974–1978	83	69	58	47	35	*
1979–1983	81	67	60	42	41	0
1984–1988	78	64	60	42	36	0
1989–1993	80	66	61	47	30	41
1994–1998	84	68	62	51	30	65
1999–2003	85	70	64	47	32	52
Sweden
1964–1968	75	64	54	35	32	*
1969–1973	76	65	58	35	30	0
1974–1978	81	66	56	38	33	0
1979–1983	83	55	57	46	26	0
1984–1988	82	62	54	43	47	17
1989–1993	85	68	54	44	33	17
1994–1998	86	68	55	45	26	0
1999–2003	86	69	54	47	29	10

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

^* Too few patients to calculate survival, see reference [11].

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of cervix uteri by country and time since diagnosis. Nordic cancer survival study 1964–2003.

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of corpus uteri by country. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for cancer of corpus uteri by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Women
1964–1968	2 170	61 (58–64)	1 386	57 (53–60)	57	67 (51–89)	1 190	55 (52–60)	3 658	65 (62–67)
1969–1973	2 268	63 (60–66)	1 658	61 (57–65)	70	63 (50–79)	1 436	65 (61–69)	4 003	68 (66–70)
1974–1978	2 742	68 (65–70)	1 975	70 (66–73)	71	69 (57–85)	1 712	71 (68–74)	4 493	72 (70–74)
1979–1983	3 243	72 (70–74)	2 176	72 (69–75)	83	64 (54–75)	1 890	71 (68–74)	4 560	73 (72–75)
1984–1988	3 112	72 (70–75)	2 388	72 (70–75)	86	68 (56–82)	1 928	71 (68–73)	4 598	76 (75–78)
1989–1993	3 194	77 (75–79)	2 863	76 (74–78)	100	64 (54–77)	2 196	74 (72–77)	5 211	78 (76–79)
1994–1998	2 981	80 (77–82)	3 280	79 (77–81)	116	67 (57–77)	2 369	77 (75–79)	5 924	83 (81–84)
1999–2003	3 122	79 (78–81)	3 525	83 (82–85)	115	75 (68–84)	2 846	81 (79–82)	6 394	83 (82–84)

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of corpus uteri by country and time since diagnosis. Nordic cancer survival study 1964–2003.

Table IV. Trends in 5-year age-specific relative survival in percent after cancer of corpus uteri by country. Nordic cancer survival study 1964–2003.

	Women
Age	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	88	79	65	51	31	*
1969–1973	86	79	66	53	39	*
1974–1978	85	86	75	55	44	0
1979–1983	84	87	80	64	46	0
1984–1988	90	84	80	66	43	43
1989–1993	88	88	81	73	55	32
1994–1998	82	87	82	78	69	30
1999–2003	83	87	83	76	69	36
Finland
1964–1968	92	78	64	49	6	*
1969–1973	91	83	65	50	25	*
1974–1978	90	85	74	56	52	62
1979–1983	92	89	76	63	45	54
1984–1988	93	85	79	63	47	61
1989–1993	88	91	80	71	54	66
1994–1998	89	89	84	76	58	47
1999–2003	91	90	87	80	68	47
Iceland
1964–1968	81	67	80	56	56	*
1969–1973	94	93	63	43	43	*
1974–1978	71	84	92	50	50	*
1979–1983	101	98	69	36	36	*
1984–1988	86	96	70	51	51	*
1989–1993	87	94	70	43	43	*
1994–1998	84	88	64	55	55	*
1999–2003	87	81	77	69	69	*
Norway
1964–1968	82	78	61	49	13	*
1969–1973	92	81	70	48	47	0
1974–1978	87	85	73	63	55	*
1979–1983	91	86	77	60	49	0
1984–1988	89	85	77	63	45	55
1989–1993	91	88	79	70	47	25
1994–1998	93	89	83	72	51	37
1999–2003	91	89	85	77	63	70
Sweden
1964–1968	93	86	67	51	39	65
1969–1973	94	87	72	57	39	0
1974–1978	93	89	75	64	48	54
1979–1983	92	92	82	63	42	70
1984–1988	94	91	82	68	50	23
1989–1993	91	90	83	71	57	45
1994–1998	90	91	87	77	69	58
1999–2003	90	92	87	78	73	56

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

* Too few patients to calculate survival, see reference [11].

Figure 5. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for ovarian cancer by country. Nordic cancer survival study 1964–2003.

Table V. Trends in survival for ovarian cancer by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Women
1964–1968	2 505	20 (18–23)	1 397	25 (22–28)	61	18 (13–25)	1 669	31 (28–35)	4 239	28 (26–30)
1969–1973	2 746	19 (17–20)	1 483	27 (24–30)	67	18 (13–25)	1 779	26 (24–29)	4 819	31 (30–33)
1974–1978	2 897	21 (20–23)	1 641	24 (22–27)	79	40 (28–58)	1 880	27 (25–30)	4 835	33 (32–35)
1979–1983	2 838	22 (20–23)	1 801	31 (28–33)	84	29 (20–42)	2 070	30 (28–33)	4 926	36 (34–37)
1984–1988	2 941	27 (25–29)	1 952	31 (29–33)	105	31 (23–43)	2 248	32 (30–35)	4 820	40 (38–41)
1989–1993	2 845	27 (25–29)	2 270	32 (30–34)	95	36 (27–47)	2 267	34 (32–36)	4 620	38 (37–40)
1994–1998	2 911	30 (28–32)	2 409	37 (35–39)	105	29 (21–40)	2 362	37 (35–39)	4 383	42 (40–44)
1999–2003	2 986	33 (31–34)	2 433	44 (42–45)	103	34 (28–42)	2 389	41 (39–42)	4 145	43 (42–45)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

Figure 6. Trends in age-standardised (ICSS) excess death rates per 100 person years for ovarian cancer by country and time since diagnosis. Nordic cancer survival study 1964–2003.

Table VI. Trends in 5-year age-specific relative survival in percent after ovarian cancer by country. Nordic cancer survival study 1964–2003.

	Women
Age	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	39	22	18	17	13	*
1969–1973	40	24	17	15	5	0
1974–1978	45	29	21	12	12	0
1979–1983	48	27	23	13	8	32
1984–1988	54	34	27	20	12	12
1989–1993	53	35	29	19	10	27
1994–1998	53	42	30	21	12	31
1999–2003	63	46	32	24	13	19
Finland
1964–1968	51	30	24	17	14	*
1969–1973	46	35	28	24	8	*
1974–1978	49	33	22	20	8	*
1979–1983	58	39	29	22	21	0
1984–1988	61	42	30	19	17	0
1989–1993	62	40	31	26	12	14
1994–1998	69	50	41	22	19	27
1999–2003	71	58	48	32	20	9
Iceland
1964–1968	63	21	14	10	*	*
1969–1973	63	21	14	10	*	*
1974–1978	62	40	22	42	51	*
1979–1983	50	34	16	35	16	*
1984–1988	95	22	26	13	36	*
1989–1993	82	40	26	34	15	*
1994–1998	56	30	40	10	25	82
1999–2003	68	38	56	12	6	*
Norway
1964–1968	46	35	27	30	26	*
1969–1973	46	32	25	23	13	*
1974–1978	52	31	28	20	15	51
1979–1983	57	37	30	23	16	38
1984–1988	60	38	33	25	19	57
1989–1993	61	43	33	24	20	0
1994–1998	65	47	42	25	14	17
1999–2003	68	52	47	28	18	24
Sweden
1964–1968	52	34	28	22	14	0
1969–1973	55	39	29	22	25	0
1974–1978	61	40	34	23	21	0
1979–1983	64	42	36	28	20	14
1984–1988	67	49	40	30	24	11
1989–1993	64	50	36	31	23	19
1994–1998	66	48	43	35	28	16
1999–2003	65	52	45	35	31	29

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

* Too few patients to calculate survival, see reference [11].

Figure 7. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of other female genital organs by country. Nordic cancer survival study 1964–2003.

Table VII. Trends in survival for cancer in other female genital organs by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
Women
1964–1968	433	53 (47–59)	328	43 (36–50)	9	*	306	52 (46–60)	709	47 (43–51)
1969–1973	416	61 (55–67)	341	40 (35–46)	9	*	330	55 (49–62)	742	50 (46–55)
1974–1978	525	57 (53–63)	371	49 (43–55)	11	*	429	50 (45–56)	711	56 (52–61)
1979–1983	622	58 (54–63)	375	55 (49–62)	11	*	439	50 (45–56)	797	56 (52–60)
1984–1988	539	60 (55–65)	400	46 (41–52)	18	63 (46–86)	432	52 (47–58)	866	56 (52–60)
1989–1993	621	58 (54–63)	420	54 (48–60)	10	63 (46–86)	453	54 (49–60)	940	58 (54–62)
1994–1998	665	59 (54–64)	480	54 (49–59)	15	64 (48–85)	546	58 (54–64)	998	58 (54–62)
1999–2003	631	57 (53–60)	550	55 (51–59)	16	64 (48–85)	491	63 (59–67)	1 018	57 (54–60)

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

* Too few patients to calculate survival, see reference [11].

Table VIII. Trends in 5-year age-specific relative survival in percent after cancer in other female genital organs by country. Nordic cancer survival study 1964–2003.

	Women
Age	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	74	66	53	49	28	0
1969–1973	73	68	66	49	55	0
1974–1978	84	65	58	52	35	58
1979–1983	82	65	60	55	36	41
1984–1988	72	69	63	57	42	66
1989–1993	72	65	59	57	39	0
1994–1998	80	67	61	51	43	46
1999–2003	84	68	59	44	43	39
Finland
1964–1968	60	45	42	41	31	*
1969–1973	76	58	40	31	9	0
1974–1978	74	54	54	44	22	0
1979–1983	82	53	63	44	44	0
1984–1988	77	44	59	40	15	24
1989–1993	81	60	54	48	36	40
1994–1998	69	65	57	47	35	0
1999–2003	76	65	58	45	42	22
Iceland
1964–1968	66	66	66	*	*	*
1969–1973	66	66	66	*	*	*
1974–1978	69	69	69	*	*	*
1979–1983	69	69	69	*	*	*
1984–1988	80	80	80	62	0	*
1989–1993	80	80	80	62	0	*
1994–1998	86	86	86	43	20	*
1999–2003	86	86	86	43	20	*
Norway
1964–1968	63	54	55	50	40	*
1969–1973	79	54	66	47	34	46
1974–1978	67	61	49	44	37	46
1979–1983	71	60	59	39	29	86
1984–1988	74	69	46	46	39	0
1989–1993	75	72	58	41	38	26
1994–1998	80	76	57	49	41	28
1999–2003	81	75	60	58	49	17
Sweden
1964–1968	72	53	53	38	26	68
1969–1973	76	52	52	48	31	38
1974–1978	73	62	58	51	42	15
1979–1983	76	65	58	47	45	0
1984–1988	82	61	56	51	37	54
1989–1993	70	63	63	53	42	40
1994–1998	81	69	56	51	42	39
1999–2003	73	72	56	50	40	35

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

* Too few patients to calculate survival, see reference [11].

Figure 8. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of other female genital organs by country and time since diagnosis. Nordic cancer survival study 1964–2003.

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010.

 Google Scholar